Skip to content
Home Events Reduce bleeding complications in ticagrelor and rivaroxaban treated patients undergoing emergency Cardiac Surgery | Webinar 1

Location

virtual

More Info

Register here

Date

21 Jan 2021

Time

CET
5:00 pm - 6:00 pm

Programm

Webinar

Reduce bleeding complications in ticagrelor and rivaroxaban treated patients undergoing emergency Cardiac Surgery | Webinar 1

INTERNATIONAL EXPERTS MEETING
Optimizing patient management with CytoSorb Hemoperfusion Therapy in Cardiac Surgery – Scientific evidence and clinical practice


Reduce bleeding complications in Ticagrelor and Rivaroxaban treated patients undergoing emergency Cardiac Surgery
Chair: Prof. Michael Schmoeckel, Hamburg/Germany

Thursday, January 21st
17.00-18.00 CET

  • Why is it relevant?
    Prof. Robert F Storey, Sheffield/UK 
  • How bleeding complications and costs can be reduced?
    Dr. Stephan Geidel, Hamburg/Germany 
  • Do we have a novel treatment approach to avoid re-thoracotomies?
    Dr. Nikola Bradic, Zagreb/Croatia 
  • Panel discussion
    with all participants and the audience 

awarded with 1 EBCP postgraduate credit

The meeting is designed for Cardiac Surgeons, Cardiologists, Intensivists and Perfusionists to:

  • see how cardiac surgery patients could benefit from the CytoSorb Hemoperfusion Therapy
  • extend the experience to new areas of CytoSorb therapy application
  • review the latest clinical results

Download Flyer

The event is finished.